Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 1898-1906

  McNamara, Peter J ^a,b   Syverson, Rae Ellen ^a   Milligan Myhre, Kathy ^a   Frolova, Olga ^a   Schroeder, Sarah ^a   Kidder, Joshua ^a   Hoang, Thanh ^a   Proctor, Richard A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O DODECYLGLYCEROL; 2 PHENOXYETHANOL; AROMATIC COMPOUND; BENZYL ALCOHOL DERIVATIVE; BETA IONONE; CERULENIN; DISODIUM LAURAMIDOMONOETHANOLAMIDE; DISODIUM LAUROAMPHODIACETATE; DRUG ADDITIVE; FATTY ACID SYNTHASE INHIBITOR; GALLIC ACID; GLUCOPON 220; GLYCEROL DODECYL ETHER; HEXACHLOROPHENE; ISOPRENOID; LAURETH 3; LAURETH 4; LINALOOL; MENTHOL; METHYL PARABEN; MYRETH 3 MYRISTATE; PARACETAMOL; PHENETHYL ALCOHOL; PLURONIC L 62; PLURONIC P 105; SODIUM LAURIMINODIPROPIONIC ACID; SURFACTANT; TERPINEOL; TOXIC SHOCK SYNDROME TOXIN 1; TRICLOSAN; TRIETHANOLAMINE LAURETH SULFATE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CULTURE; CULTURE MEDIUM; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TAMPON; TOXIN SYNTHESIS;

BACTERIAL TOXINS; BENZYL ALCOHOLS; CULTURE MEDIA; ENTEROTOXINS; FATTY ACID SYNTHESIS INHIBITORS; FEMALE; HUMANS; SHOCK, SEPTIC; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; SURFACE-ACTIVE AGENTS; TERPENES; VAGINA;

EID: 66149140548     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01293-08     Document Type: Article

References (34)

1. Adhikari, R. P., and R. P. Novick. 2005. Subinhibitory cerulenin inhibits staphylococcal exoprotein production by blocking transcription rather than by blocking secretion. Microbiology 151:3059-3069.
2. Altenbern, R. A. 1977. Enterotoxin B production by Staphylococcus aureus under controlled fatty acid nutrition induced by cerulenin. Can. J. Microbiol. 23:1145-1150.
3. Altenbern, R. A. 1977. Extreme sensitivity of staphylococcal enterotoxin B and C production to inhibition by cerulenin. Antimicrob. Agents Chemother. 11:906-908.
4. Bloch, K. E. 1983. Sterol structure and membrane function. CRC Crit. Rev. Biochem. 14:47-92.
5. Gill, S. R., D. E. Fouts, G. L. Archer, E. F. Mongodin, R. T. Deboy, J. Ravel, I. T. Paulsen, J. F. Kolonay, L. Brinkac, M. Beanan, R. J. Dodson, S. C. Daugherty, R. Madupu, S. V. Angiuoli, A. S. Durkin, D. H. Haft, J. Vamathevan, H. Khouri, T. Utterback, C. Lee, G. Dimitrov, L. Jiang, H. Qin, J. Weidman, K. Tran, K. Kang, I. R. Hance, K. E. Nelson, and C. M. Fraser. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187:2426-2438.
6. Goldberg, I., J. R. Walker, and K. Bloch. 1973. Inhibition of lipid synthesis in Escherichia coli cells by antibiotic cerulenin. Antimicrob. Agents Chemother. 3:549-554.
7. Heath, R. J., J. Li, G. E. Roland, and C. O. Rock. 2000. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. J. Biol. Chem. 18:4654-4659.
8. Holland, K. T., D. Taylor, and A. M. Farrell. 1994. The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus. Antimicrob. Agents Chemother. 33:41-55.
9. Koch, A. L. 1994. Growth measurement, p. 248-277. In P. Gerhardt, R. G. E. Murray, R. N. Costilow, E. W. Nester, W. A. Wood, N. R. Krieg, and G. B. Phillips (ed.), Manual of methods for general bacteriology. American Society for Microbiology, Washington, DC.
10. Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ito, M. Kanamori, H. Matsumaru, A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K. Furuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
11. Lee, K. Y., and T. H. Birbeck. 1985. Effect of phenethyl alcohol on Staphylococcus aureus alpha-lysin production. Infect. Immun. 47:112-117.
12. Melish, M., S. Fukunaga, and S. Murata. 1998. Effect of glycerol monolaurate (GML) and pluronic L92 (PL92) on illness and TSST-1 production in a subcutaneous depot model for TSS, p. 144. In J. Arbuthmott and B. Furman (ed.), European Conference on Toxic Shock Syndrome, vol.229. Royal Society of Medicine Services, London, United Kingdom.
13. Nunn, W. D. 1975. The inhibition of phospholipids synthesis in Escherichia coli by phenethyl alcohol. Biochim. Biophys. Acta 380:403-413.
14. Onderdonk, A. B., G. R. Zamarchi, M. L. Rodriguez, M. L. Hirsch, A. Munoz, and E. H. Kass. 1987. Qualitative assessment of vaginal microflora during use of tampons of various compositions. Appl. Environ. Microbiol. 53:2779-2784.
15. Peterson, M. L., and P. M. Schlievert. 2006. Glycerol monolaurate inhibits the effects of gram-positive select agents on eukaryotic cells. Biochemistry 45:2387-2397.
16. Price, A. C., K. H. Choi, R. J. Heath, Z. Li, S. W. White, and C. O. Rock. 2001. Inhibition of β-ketoacyl-aacyl carrier protein synthase by thiolactomycin and cerulenin: structure and mechanism. J. Biol. Chem. 276:6551-6559.
17. Projan, S. J., S. Brown-Skrobot, P. M. Schlievert, F. Vandenesch, and R. P. Novick. 1994. Glycerol monolaurate inhibits the production of β-lactamase, toxic shock syndrome toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J. Bacteriol. 176:4204-4209.
18. Robbins, R. N., B. J. Kelly, G. L. Hehl, and M. S. Bergdoll. 1989. Effect of tampon wraps on production of toxic shock syndrome toxin-1. Rev. Infect. Dis. 11:S197-S202.
19. Ruzin, A., and R. P. Novick. 1998. Glycerol monolaurate inhibits induction of vancomycin resistance in Enterococcus faecalis. J. Bacteriol. 180:182-185.
20. Ruzin, A., and R. P. Novick. 2000. Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus. J. Bacteriol. 182:2668-2671.
21. Saleh, F. A., and J. H. Freer. 1982. Inhibition of secretion of staphylococcal alpha toxin by cerulenin. J. Med. Microbiol. 18:205-216.
22. Schlievert, P. M. 2005. Staphylococcal toxic shock syndrome: still a problem. Med. J. Aust. 182:651-652.
23. Schlievert, P. M., and D. A. Blomster. 1983. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J. Infect. Dis. 147:236-242.
24. Schlievert, P. M., D. A. Blomster, and J. A. Kelly. 1984. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production. Obstet. Gynecol. 64:666-671.
25. Schlievert, P. M., J. R. Deringer, M. H. Kim, S. J. Projan, and R. P. Novick. 1992. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob. Agents Chemother. 36:626-631.
26. Shands, K. N., G. P. Schmid, B. B. Dan, D. Blum, R. J. Guidotti, N. T. Hargrett, R. L. Anderson, D. L. Hill, C. V. Broome, J. D. Band, and D. W. Fraser. 1980. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303:1436-1442.
27. Silver, S., and L. Wendt. 1967. Mechanism of action of phenethyl alcohol: breakdown of the cellular permeability barrier. J. Bacteriol. 93:560-566.
28. Slater-Radosti, C., G. Van Aller, R. Greenwood, R. Nicholas, P. M. Keller, W. E. DeWolf, Jr., F. Fan, D. J. Payne, and D. D. Jaworski. 2001. Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. Antimicrob. Chemother. 48:1-6.
29. Stim-Herndon, K. P. 1995. Effect of the local anesthetics phenethyl alcohol and procaine on hns mutants of the acid-induced biodegradative arginine (adi) and lysine (cad) decarboxylases of Escherichia coli. Curr. Microbiol. 130:281-285.
30. Syverson, R. E. June 1995. Inhibition of exoprotein in absorbent article. U.S. patent 5,612,045.
31. Syverson, R. E. June 1995. Inhibition of exoprotein using amide compositions in absorbent article. U.S. patent 5,685,872.
32. Syverson, R. E. June 1995. Inhibition of exoprotein using amine compositions in absorbent article and method thereof. U.S. patent 5,618,554.
33. Vetter, S. M., and P. M. Schlievert. 2005. Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis. Antimicrob. Agents Chemother. 49:1302-1305.
34. Wong, A. C. L. 1987. Factors affecting growth of Staphylococcus aureus and production of toxic shock syndrome-1. Ph.D. thesis. University of Wisconsin, Madison.